ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. It markets, sells, and distributes its products through wholesalers, retail market chains, distributors and specialty pharmacies, group purchasing organizations, specialty pharmacies, hospitals, clinics, and physicians. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota. Show more
Location: 210 Main Street West, Baudette, MN, 56623, United States | Website: https://www.anipharmaceuticals.com | Industry: Drug Manufacturers - Specialty & Generic | Sector: Healthcare
Market Cap
1.412B
52 Wk Range
$52.50 - $77.00
Previous Close
$65.22
Open
$65.20
Volume
98,504
Day Range
$63.74 - $65.72
Enterprise Value
1.806B
Cash
155.2M
Avg Qtr Burn
N/A
Insider Ownership
11.10%
Institutional Own.
-
Qtr Updated
03/31/25
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|